Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus

15 Mar 2023

Abstract excerpt

Background: Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7), and insulin resistance in visceral adipose tissue (VAT) and peripheral blood mononuclear cells (PBMCs) in type 2 diabetes mellitus (T2DM) patients. Methods: Sixty patients,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to GDF15 and Related Biomarkers
Share to IL-33, ST2, and ILC Pathways
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36918405
DOI: 10.7570/jomes22010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes MellitusPMID 36918405Read ↗

Correlations between growth differentiation factor 15 (GDF-15) serum levels and gene polymorphism with type 2 diabetes mellitusSemantic proximity Read ↗

Investigating the role of GDF-15 in diabetes and obesity: A comprehensive analysis of a cohort from the KEDP-studySemantic proximity Read ↗

A clinical and in-silico analysis of hsa-miR-21 and Growth Differentiation factor-15 expression in Diabetic NephropathySemantic proximity Read ↗

GDF-15 levels in patients with polycystic ovary syndrome treated with metformin: a combined clinical and in silico pathway analysisSemantic proximity Read ↗

Association between growth differentiation factor 15 levels and gestational diabetes mellitus: A combined analysisSemantic proximity Read ↗

Growth differentiation factor 15: A novel biomarker with high clinical potentialSemantic proximity Read ↗

Construction of a novel miRNA regulatory network and identification of target genes in gestational diabetes mellitus by integrated analysisSemantic proximity Read ↗

Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization studySemantic proximity Read ↗

GDF15 and Growth ControlSemantic proximity Read ↗

Growth differentiation factor 15 and its role in carcinogenesis: an updateSemantic proximity Read ↗

Genetically proxied growth differentiation factor 15 levels and body mass indexSemantic proximity Read ↗

Integrated miRNA–mRNA Analysis Reveals Dysregulated Regulatory Networks in Visceral Adipose Tissue Linked to Obesity and Type 2 DiabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.